Neurologic Manifestation of Chikungunya Virus

Current Infectious Disease Reports

Volumn 19, Issue 2, 2017, Pages

  Brizzi, Kate ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chikungunya; Encephalitis; Guillain Barre syndrome; Mosquito borne viruses; Neurology

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; STEROID; VIRUS RNA;

APOPTOSIS; ASTROCYTE; CEREBELLAR ATAXIA; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; COGNITIVE DEFECT; CRANIAL NERVE PARALYSIS; CRANIAL NEUROPATHY; DEMYELINATING DISEASE; ENCEPHALITIS; ENCEPHALOMYELITIS; ENDEMIC DISEASE; GUILLAIN BARRE SYNDROME; HUMAN; INNATE IMMUNITY; MENTAL DISEASE; MYELITIS; MYELORADICULOPATHY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; OPTIC NEURITIS; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; REVIEW; RHEUMATIC DISEASE; SEIZURE; SPINAL CORD DISEASE; SYMPTOMATOLOGY;

EID: 85013818957     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-017-0561-1     Document Type: Review

References (44)

1. Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT. Chikungunya: a re-emerging virus. Lancet. 2012;379(9816):662–71.
2. •• Deeba F, Islam A, Kazim SN, Naqvi IH, Broor S, Ahmed A, Parveen S. Chikungunya virus: recent advances in epidemiology, host pathogen interaction and vaccine strategies. Pathog Dis. 2016;74(3). pii: ftv119. A recent review of the epidemiology of Chikungunya.
3. •• Weaver SC, Forrester NL. Chikungunya: evolutionary history and recent epidemic spread. Antiviral Res. 2015;120:32–9. A discussion of the global spread of Chikungunya.
4. •• Carneiro LA, Travassos LH. Autophagy and viral diseases transmitted by Aedes aegypti and Aedes albopictus. Microbes Infect. 2016;18(3):169–71. The pathophysiology of viruses spread by the mosquito that carries Chikungunya.
5. •• Petersen LR, Powers AM. Chikungunya: epidemiology. F1000Res. 2016;5. pii: F1000 Faculty Rev-82. A comprehensive review of the epidemiology of Chikungunya and the factors contributing to the spread of disease.
6. Gérardin P, Guernier V, Perrau J, Fianu A, Le Roux K, Grivard P, et al. Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis. 2008;8:99.
7. • Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3(12):e201. This study demonstrated an envelope protein mutation in the virus that may explain changes in the global spread of Chikungunya virus.
8. Angelini R, Finarelli AC, Angelini P, Po C, Petropulacos K, Silvi G, et al. Chikungunya in north-eastern Italy: a summing up of the outbreak. Euro Surveill. 2007;12(11):E071122.2.
9. Teixeira MG, Andrade AM, Costa Mda C, Castro JN, Oliveira FL, Goes CS, et al. East/Central/South African genotype Chikunguya virus, Brazil, 2014. Emerging Infect Dis. 2015;21(5):906–7.
10. World Health Organization. Chikungunya [Internet]. Geneva: World Health Organization; 2016 Apr [cited 2016 Aug 28]. Available from: http://www.who.int/mediacentre/factsheets/fs327/en/.
11. Centers for Disease Control (US). Chikungunya Virus: 2015 final data for the United States [Internet]. Atlanta: Centers for Disease Control and Prevention; 2016 June [cited 2016 Aug 28]. Available from: https://www.cdc.gov/chikungunya/geo/united-states-2015.html.
12. •• Kendrick K, Stanek D, Blackmore C, Centers for Disease Control and Prevention (CDC). Notes from the field: transmission of Chikungunya virus in the continental United States—Florida, 2014. MMWR Morb Mortal Wkly Rep. 2014;63(48):1137. This paper is a quantification of Chikungunya cases in the United States.
13. •• Priya R, Patro IK, Parida MM. TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus. Virus Res. 2014;189:194–205. A study demonstrating the immune response following Chikungunya infection.
14. •• Inglis FM, Lee KM, Chiu KB, Purcell OM, Didier PJ, Russell-Lodrigue K, et al. Neuropathogenesis of Chikungunya infection: astrogliosis and innate immune activation. J Neurovirol. 2016;22(2):140–8. A discussion of the immune response following Chikungunya infection.
15. •• Chiam CW, Chan YF, Ong KC, Wong KT, Sam IC. Neurovirulence comparison of Chikungunya virus isolates of the Asian and East/Central/South African genotypes from Malaysia. J Gen Virol. 2015;96(11):3243–54. A study illustrating the difference in neurovirulence of Chikungunya virus based on genotype.
16. Sissoko D, Moendandze A, Malvy D, Giry C, Ezzedine K, Solet JL, et al. Seroprevalence and risk factors of Chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PLoS One. 2008;3(8):e3066.
17. Sm A, Lai LR, Chan YF, Hatim A, Hairi NN, Ayob A, et al. Seroprevalence survey of Chikungunya virus in Bagan Panchor, Malaysia. Am J Trop Med Hyg. 2010;83(6):1245–8.
18. Manimunda SP, Sugunan AP, Rai SK, Vijayachari P, Shriram AN, Sharma S, et al. Outbreak of Chikungunya fever, Dakshina Kannada District, South India, 2008. Am J Trop Med Hyg. 2010;83(4):751–4.
19. Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N, Becquart JP, et al. Outbreak of Chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis. 2007;44(11):1401–7.
20. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, et al. Post epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis. 2009;3:e389.
21. •• Rodriguez-Morales AJ, Gil-Restrepo AF, Ramírez-Jaramillo V, Montoya-Arias CP, Acevedo-Mendoza WF, Bedoya-Arias JE, et al. Post-Chikungunya chronic inflammatory rheumatism: results from a retrospective follow-up study of 283 adult and child cases in La Virginia, Risaralda, Colombia. Version 2. F1000Res. 2016 Mar 16 [revised 2016 Apr 4];5:360. A retrospective review of the non-neurologic clinical effects of Chikungunya virus.
22. Suryawanshi SD, Dube AH, Khadse RK, Jalgaonkar SV, Sathe PS, Zawar SD, et al. Clinical profile of Chikungunya fever in patients in a tertiary care centre in Maharashtra, India. Indian J Med Res. 2009;129(4):438–41.
23. • Chandak NH, Kashyap RS, Kabra D, Karandikar P, Saha SS, Morey SH, et al. Neurological complications of Chikungunya virus infection. Neurol India. 2009;57(2):177–80. A prior review of the neurologic syndromes associated with Chikungunya infection seen in a cohort from India.
24. Tandale BV, Sathe PS, Arankalle VA, Wadia RS, Kulkarni R, Shah SV, et al. Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. J Clin Virol. 2009;46(2):145–9.
25. Crosby L, Perreau C, Madeux B, Cossic J, Armand C, Hermann-Storke C, et al. Severe manifestations of Chikungunya virus in critically ill patients during the 2013-2014 Caribbean outbreak. Int J Infect Dis. 2016;48:78–80.
26. • Gérardin P, Couderc T, Bintner M, Tournebize P, Renouil M, Lémant J, et al. Chikungunya virus-associated encephalitis: a cohort study on La Réunion Island, 2005-2009. Neurology. 2016;86(1):94–102. A comprehensive study examining neurologic syndromes in patients with Chikungunya virus on La Reunion Island.
27. Chusri S, Siripaitoon P, Hirunpat S, Silpapojakul K. Case reports of neuro-Chikungunya in southern Thailand. Am J Trop Med Hyg. 2011;85(2):386–9.
28. Casolari S, Briganti E, Zanotti M, Zauli T, Nicoletti L, Magurano F, et al. A fatal case of encephalitis associated with Chikungunya virus infection. Scand J Infect Dis. 2008;40(11–12):995–6.
29. •• Maity P, Roy P, Basu A, Das B, Ghosh US. A case of ADEM following Chikungunya fever. J Assoc Physicians India. 2014;62(5):441–2. An illustrative case of demyelinating disease following Chikungunya infection.
30. Gauri LA, Ranwa B, Nagar K, Vyas A, Fatima Q. Post Chikungunya brain stem encephalitis. J Assoc Physicians India. 2012;60:68–70.
31. Ganesan K, Diwan A, Shankar SK, Desai SB, Sainani GS, Katrak SM. Chikungunya encephalomyeloradiculitis: report of 2 cases with neuroimaging and 1 case with autopsyfindings. AJNR Am J Neuroradiol. 2008;29(9):1636–7.
32. •• Kalita J, Kumar P, Misra UK. Stimulus-sensitive myoclonus and cerebellar ataxia following Chikungunya meningoencephalitis. Infection. 2013;41(3):727–9. A unique case study of cerebellar ataxia following Chikungunya infection.
33. •• Bank AM, Batra A, Colorado RA, Lyons JL. Myeloradiculopathy associated with Chikungunya virus infection. J Neurovirol. 2016;22(1):125–8. A case study demonstrating myeloradiculopathy following Chikungunya virus with response to treatment.
34. •• Brasil P, Sequeira PC, Freitas AD, Zogbi HE, Calvet GA, de Souza RV, et al. Guillain-Barré syndrome associated with Zika virus infection. Lancet. 2016;387(10026):1482. A case study of a patient with GBS following Zika virus with CSF analysis.
35. •• Oehler E, Fournier E, Leparc-Goffart I, Larre P, Cubizolle S, Sookhareea C, et al. Increase in cases of Guillain-Barré syndrome during a Chikungunya outbreak, French Polynesia, 2014 to 2015. Euro Surveill. 2015;20(48):30079. A retrospective review of cases demonstrating correlation between increased GBS cases and the Chikungunya outbreak in French Polynesia.
36. Lebrun G, Chadda K, Reboux AH, Martinet O, Gaüzère BA. Guillain-Barré syndrome after Chikungunya infection. Emerg Infect Dis. 2009;15(3):495–6.
37. Wielanek AC, Monredon JD, Amrani ME, Roger JC, Serveaux JP. Guillain-Barré syndrome complicating a Chikungunya virus infection. Neurology. 2007;69(22):2105–7.
38. Mittal A, Mittal S, Bharati MJ, Ramakrishnan R, Saravanan S, Sathe PS. Optic neuritis associated with Chikungunya virus infection in South India. Arch Ophthalmol. 2007;125:1381–6.
39. •• Mohite AA, Agius-Fernandez A. Chikungunya fever presenting with acute optic neuropathy. BMJ Case Rep. 2015 Jul 28;2015. pii: bcr2015210081. A case report of a patient with optic neuropathy following Chikungunya infection.
40. •• Benzekri R, Hage R, Merle H. Third cranial nerve palsy in the setting of Chikungunya virus infection. Am J Trop Med Hyg. 2016;95(1):180–1. A case report of a patient with a cranial nerve III palsy following Chikungunya infection.
41. Gérardin P, Fianu A, Malvy D, Mussard C, Boussaïd K, Rollot O, et al. Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study. BMC Med. 2011;9:5.
42. •• Bhatia MS, Gautam P, Jhanjee A. Psychiatric morbidity in patients with Chikungunya fever: first report from India. J Clin Diagn Res. 2015;9(10):VC01–3. One of the few reports of the psychiatric comorbidities associated with Chikungunya virus.
43. Kashyap RS, Morey SH, Chandak NH, Purohit HJ, Taori GM, Daginawala HF. Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications. Cerebrospinal Fluid Res. 2010;7:12.
44. •• Leibovitch EC, Jacobson S. Vaccinations for neuroinfectious disease: a global health priority. Neurotherapeutics. 2016. [Epub ahead of print]. A discussion of the current state of vaccine development for Chikungunya infection.